Where this information about brain tumours comes from

All our information is checked by cancer specialists and surgeons who specialise in treating cancer. The names of our specialist reviewers are at the end of this list. We also try to find patients to review all our sections. If you have had a brain tumour, live in the UK, and would like to become a patient reviewer, you can write to us by clicking on contact us.

Cancer Research UK
CancerStats series - Brain and other central nervous system tumours

National Cancer Institute - US National Institute of Health
Brain tumor information section

Mobile Telecommunications and Health Research Programme (MTHR)
Link to MTHR website

Principles and practice of oncology (8^th edition)
De Vita, V.T., Hellman, S. and Rosenberg S.A.
Lippincott, Wiliams and Wilkins, 2008

Cancer and its management (6th edition)
Tobias J. and Hochhauser D.
Blackwell Publishing Ltd, 2010

Long term follow up of survivors of childhood cancer
Scottish Intercollegiate Guidelines Network, 2004 - link to the SIGN guidelines

Referral Guidelines for Suspected Cancer
National Institute for Health and Clinical Excellence, June 2005 - link to the NICE cancer referral guidelines.

Improving outcomes for people with brain and other CNS tumours
National Institute for Health and Clinical Excellence, June 2006 - link to the NICE brain tumour guidelines

Improving outcomes in children and young people with cancer
National Institute for Health and Clinical Excellence, August 2005 - link to the NICE guidelines

National Institute for Health and Clinical Excellence Appraisals

• Photodynamic therapy for brain tumours - March 2009
• Carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma - June 2007
• Endoscopic transsphenoidal pituitary adenoma resection - December 2003
• Temozolomide for recurrent glioma - April 2001

CBTRUS Statistical report of primary brain and central nervous system tumours diagnosed in the United States in 2004-2006. Central brain tumour registry of the United States. Feb 2010.

Low-grade Astrocytoma. Gallo J, e-medicine. Jan 8 2010. 

Whole brain radiotherapy for the treatment of multiple brain metastases. Tsao MN, Lloyd N, Wong RKS, Chow E, Rakovitch E, Laperriere N. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD003869. 

Long-term efficacy of early versus delayed radiotherapy for low grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. van den Bent et al. The Lancet. 2005; 366: 985–90.

Supratentorial grade II astrocytoma: biological features and clinical course. P. Wessels, W. Weber, G. Raven, F. Ramaekers, A. Hopman, A. Twijnstra. The Lancet Neurology. 2003, Volume 2, Issue 7, Pages 395-403.

Chemotherapy for high-grade glioma. Stewart L, Burdett S. Glioma Meta-analysis Trialists Group (GMT). Cochrane Database of Systematic Reviews 2003, Issue 3. Art. No.: CD003913.

Cancer and cellular telephones - a Danish nationwide survey. C Johansen et al. Cellular telephones and cancer - a nationwide cohort study in Denmark. Journal of the National cancer Institute. 2001, 93: 203-207.

Emerging Clinical Principles on the use of Bevacizumab for the treatment of malignant gliomas. Chamberlain, M. Cancer. 2010; 3988-3999.

Antiangiogenic agents in the treatment of recurrent or newly diagnosed glioblastoma: Analysis of single agent and combined modality approaches. Beal K, Abrey L, Gutin P. Radiation Oncology 2011, 6:2

High grade malignant glioma:ESMO Clinical Practice Guidelines for diagnosis, treatment and follow up. Stupp R, Tonn JC, Brada M and Pentheroudakis G. Annals of Oncology 2010, 21 (supplement 5): v190-v193

Dr I Geh, MRCP FRCR
Dr Richard Grundy MBChB
Mr Sanj Bassi, Consultant Neurosurgeon
Ms T Hood, BPhil (Counselling) SRN OND Adv. Dip
Mrs Ros Mitchell, MBBS, MD, FRCS(SN)
Dr Barry Pizer, FRCPCH, MRCP, MBChB, PhD
Mr J Punt, MBBS FRCS, FRCP CH
Dr Susan Short, MBBS, BSc, MRCP, FRCR, PhD

Dee McLean - McDee Art, Medical Illustration